Risk category | Low-risk group (NÂ =Â 154) | Non-low-risk group (NÂ =Â 67) | ||
---|---|---|---|---|
Recommendation, n | CTÂ +Â HT | HT | CTÂ +Â HT | HT |
1st tumor board | 41 (27%) | 113 (73%) | 48 (72%) | 19 (28%) |
1st shared decision | 40 (26%) | 114 (74%) | 47 (70%) | 20 (30%) |
 | Add knowledge of recurrence score | |||
2nd tumor board | 28 (18%) | 126 (82%) | 32 (48%) | 35 (52%) |
2nd shared decision | 24 (16%) | 130 (84%) | 32 (48%) | 35 (52%) |
Treatment actually given | 23 (15%) | 130 (84%) | 28 (42%) | 37 (55%) |